secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2024-10-21T23:59:59+00:00
Accession:  0001396814-24-000129
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira BioSciences appoints Shawn Cross as CFO effective Oct 21, 2024
---------------------------------------------------------------------

- Shawn Cross appointed CFO effective Oct 21, 2024; succeeds interim CFO Lauren Riker, who remains SVP of Finance.
- Cross brings >25 years of biopharma experience; former CEO/President/CFO of Applied Molecular Transport.
- Annual base salary $525K; annual bonus target 50% of base; inducement awards of 200K stock options and 75K RSUs.
- Inducement awards vest over four years; option exercise price equals Nov 4, 2024 closing price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/0001396814-24-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681424000129/pcrx-20241016.htm
  HTML page:      https://secwatch.observer/filing/0001396814-24-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer